Acadia Pharmaceuticals Inc (ACAD)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Baker Bros. Advisors

Julian Baker And Felix Baker

42,877,916 $786,809,759 8.4%
2.
D E Shaw

D. E. Shaw

3,241,406 $59,479,800 -8% 0.04%
3.
Palo Alto Investors

William Leland Edwards

2,748,599 $50,436,792 +9% 7.81%
4. 2,230,815 $40,935,455 0.09%
5. 1,500,000 $27,525,000 1.82%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$25.65 259,109 Large Shareholder, Director 39,317,673 2023-05-24 Filing
$25.65 24,113 Large Shareholder, Director 3,610,443 2023-05-24 Filing
$25.51 28,878 Large Shareholder, Director 39,058,564 2023-05-24 Filing
$25.51 2,688 Large Shareholder, Director 3,586,330 2023-05-24 Filing
$25.27 218,171 Large Shareholder, Director 39,029,686 2023-05-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.81 10,329 62,105 2024-11-19 Filing
$16.81 4,073 19,863 2024-11-19 Filing
$16.81 10,259 53,302 2024-11-19 Filing
$15.28 9,733 43,735 2024-08-19 Filing
$15.28 9,534 52,177 2024-08-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 13,947,640 $255,939,195 0%
2. 12,729,859 $233,592,914 0%
3. 8,705,501 $159,745,943 2.41%
4. 7,297,049 $133,900,859 0%
5. 4,521,385 $82,967,415 0%
News See All